Stock SGMO SANGAMO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Sangamo Therapeutics, Inc.

Equities

SGMO

US8006771062

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
0.6496 USD +6.72% Intraday chart for Sangamo Therapeutics, Inc. +15.71% +19.57%
05-09 Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09 Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SANGAMO THERAPEUTICS, INC. Stock Sangamo Therapeutics, Inc.
 135M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.84B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. SGMO Stock
  4. Charts Sangamo Therapeutics, Inc.
  5. Sector Chart